Bronchiolitis Obliterans Syndrome (BOS) Enrolling by Invitation Phase 3 Trials for Cyclosporine (DB00091)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Enrolling by Invitation3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04039347Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)Treatment